Hepatorenal Syndrome News and Research

RSS
Study finds lower levels of liver decompensation in pregnant women with cirrhosis

Study finds lower levels of liver decompensation in pregnant women with cirrhosis

Drinking during late adolescence could be first step to liver problems in adulthood

Drinking during late adolescence could be first step to liver problems in adulthood

Cumberland initiates clinical development of Boxaban (ifetroban) oral capsule for AERD treatment

Cumberland initiates clinical development of Boxaban (ifetroban) oral capsule for AERD treatment

Combination drug does not improve survival in patients with severe alcoholic hepatitis

Combination drug does not improve survival in patients with severe alcoholic hepatitis

PharmaIN receives FDA orphan-drug designation for terlipressin to treat ascites

PharmaIN receives FDA orphan-drug designation for terlipressin to treat ascites

TGA approves Ikaria’s LUCASSIN to treat Hepatorenal Syndrome Type 1

TGA approves Ikaria’s LUCASSIN to treat Hepatorenal Syndrome Type 1

Cumberland acquires Vanderbilt's ifetroban rights

Cumberland acquires Vanderbilt's ifetroban rights

Ikaria initiates enrollment in LUCASSIN Phase III trial for HRS Type 1

Ikaria initiates enrollment in LUCASSIN Phase III trial for HRS Type 1

Recommendations available for managing ascites, SBP and hepatorenal syndrome

Recommendations available for managing ascites, SBP and hepatorenal syndrome

Extracorporeal liver support therapy valued as detoxification treatment option for patients with cirrhosis

Extracorporeal liver support therapy valued as detoxification treatment option for patients with cirrhosis

Ikaria Holdings acquires NDA and IND application for LUCASSIN drug

Ikaria Holdings acquires NDA and IND application for LUCASSIN drug

Transplantation of human mononuclear cells exerts a deleterious effect in rats with liver cirrhosis

Transplantation of human mononuclear cells exerts a deleterious effect in rats with liver cirrhosis

Global prevalence of kidney failure among critically ill patients

Global prevalence of kidney failure among critically ill patients

GenoMed to be awarded new patent, for treating acute kidney failure without dialysis

GenoMed to be awarded new patent, for treating acute kidney failure without dialysis

Fast Track designation for Terlipressin in type 1 hepatorenal syndrome

Fast Track designation for Terlipressin in type 1 hepatorenal syndrome

Short-term use of selective COX-2 inhibitors may be safe for patients with cirrhosis of the liver

Short-term use of selective COX-2 inhibitors may be safe for patients with cirrhosis of the liver